Cellular Expansion (NANEX)

The fundamental challenge in the development of any stem cell therapy is the difficulty in obtaining sufficient numbers of stem cells to create a therapeutically active dose. Because of the scarcity of stem cells in human tissue, efficient expansion strategies are necessary to consistently produce them in effective quantities. Arteriocyte’s NANEX technology (ex vivo expansion system) has been demonstrated to rapidly yield greater than a 250 fold increase of stem cells. The NANEX technology is in pre-clinical evaluation as a system that will enable production of stem cell therapies from significantly lower volume tissue harvests.